Persistent Pneumonic Consolidations due to Secondary Organizing Pneumonia in a Patient Recovering from COVID-19 Pneumonia: A Case Report and Literature Review
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In patients recovering from coronavirus disease 2019 (COVID-19) pneumonia, respiratory symptoms and radiographic pneumonic infiltrate occasionally persist for many weeks even after viral clearance; thereby, making it difficult to decide on an appropriate treatment. Here, we describe a 46-year-old woman with COVID-19 pneumonia who had persistent radiographic pneumonic infiltration and respiratory symptoms for almost 4 weeks after illness onset, despite viral clearance, and was subsequently diagnosed with secondary organizing pneumonia (SOP) using video-assisted thoracoscopic (VATS) wedge lung biopsy. Intravenous methylprednisolone was administered at an initial dose of 50 mg/day (1 mg/kg) for 7 days and was tapered to a dose of prednisolone 30 mg/day following improvement in the patient’s respiratory symptoms and chest radiographic findings. The patient was discharged from the hospital 14 days after the initiation of corticosteroid treatment. The dose of prednisolone was tapered monthly to 20, 15, 10, and 5 mg/day, respectively, at the outpatient clinic for a total duration of 6 months; nearly resolved pneumonic infiltrations were observed in a follow-up computed tomography scan approximately 2 months after she was admitted. To the best of our knowledge, this is the first case report of a COVID-19 associated SOP that was pathologically confirmed through VATS wedge lung biopsy in Korea. SOP should be considered in the differential diagnosis of patients with COVID-19 pneumonia with persistent respiratory symptoms and radiographic pneumonic infiltrations during the recovery phase to avoid the redundant use of antimicrobial or antiviral agents. Furthermore, histological confirmation is essential for the definitive diagnosis of SOP to avoid unnecessarily prolonged corticosteroid treatment.
Abstract
In patients recovering from coronavirus disease 2019 (COVID-19) pneumonia, respiratory symptoms and radiographic pneumonic infiltrate occasionally persist for many weeks even after viral clearance; thereby, making it difficult to decide on an appropriate treatment. Here, we describe a 46-year-old woman with COVID-19 pneumonia who had persistent radiographic pneumonic infiltration and respiratory symptoms for almost 4 weeks after illness onset, despite viral clearance, and was subsequently diagnosed with secondary organizing pneumonia (SOP) using video-assisted thoracoscopic (VATS) wedge lung biopsy. Intravenous methylprednisolone was administered at an initial dose of 50 mg/day (1 mg/kg) for 7 days and was tapered to a dose of prednisolone 30 mg/day following improvement in the patient’s respiratory symptoms and chest radiographic findings. The patient was discharged from the hospital 14 days after the initiation of corticosteroid treatment. The dose of prednisolone was tapered monthly to 20, 15, 10, and 5 mg/day, respectively, at the outpatient clinic for a total duration of 6 months; nearly resolved pneumonic infiltrations were observed in a follow-up computed tomography scan approximately 2 months after she was admitted. To the best of our knowledge, this is the first case report of a COVID-19 associated SOP that was pathologically confirmed through VATS wedge lung biopsy in Korea. SOP should be considered in the differential diagnosis of patients with COVID-19 pneumonia with persistent respiratory symptoms and radiographic pneumonic infiltrations during the recovery phase to avoid the redundant use of antimicrobial or antiviral agents. Furthermore, histological confirmation is essential for the definitive diagnosis of SOP to avoid unnecessarily prolonged corticosteroid treatment.
참고문헌 (18)
- Alkodaymi MS, "Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods : a systematic review and meta-analysis", Clin Microbiol Infect, 28, pp.657~666 (2022)
- Pan F, "Time course of lung changes at chest CT during recovery from coronavirus disease 2019(COVID-19)", Radiology, 295, pp.715~721 (2020)
- Drakopanagiotakis F, "Organizing pneumonia", Am J Med Sci, 335, pp.34~39 (2008)
- Wong KT, "Severe acute respiratory syndrome : thin-section computed tomography features, temporal changes, and clinicoradiologic correlation during the convalescent period", J Comput Assist Tomogr, 28, pp.790~795 (2004)
- Cheung OY, "The spectrum of pathological changes in severe acute respiratory syndrome(SARS)", Histopathology, 45, pp.119~124 (2004)
- Myall KJ, "Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment", Ann Am Thorac Soc, 18, pp.799~806 (2021)
- Golbets E, "Secondary organizing pneumonia after recovery of mild COVID-19 infection", J Med Virol, 94, pp.417~423 (2022)
- Kanaoka K, "Secondary organizing pneumonia after coronavirus disease 2019 : Two cases", Respir Med Case Rep, 32, pp.101356~ (2021)
- Klein F, "Transbronchial biopsies’ histopathological findings leading to successful late steroid therapy in Covid-19 acute respiratory failure", Virchows Arch, 479, pp.827~833 (2021)
- Nakakubo S, "Delayed-onset organizing pneumonia emerging after recovery from coronavirus disease 2019 : A report of three cases diagnosed using transbronchial cryobiopsy and a review of the literature", Intern Med, 61, pp.1403~1410 (2022)
- Pogatchnik BP, "Radiology-pathology correlation demonstrating organizing pneumonia in a patient who recovered from COVID-19", Am J Respir Crit Care Med, 202, pp.598~599 (2020)
- Takumida H, "Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid", Respir Investig, 59, pp.377~381 (2021)
- Vadász I, "Severe organising pneumonia following COVID-19", Thorax, 76, pp.201~204 (2021)
- Kostorz-Nosal S, "A prolonged steroid therapy may be beneficial in some patients after the COVID-19 pneumonia", Eur Clin Respir J, 8, pp.1945186~ (2021)
- Simões JP, "Organizing pneumonia and COVID-19 : A report of two cases", Respir Med Case Rep, 32, pp.101359~ (2021)
- RECOVERY Collaborative Group, "Dexamethasone in hospitalized patients with Covid-19", N Engl J Med, 384, pp.693~704 (2021)
- Kumar N, "Virological and immunological outcomes of coinfections", Clin Microbiol Rev, 31, pp.e00111-17~ (2018)
- Seo Hyeonji, "Radiologically Suspected Organizing Pneumonia in a Patient Recovering from COVID-19: A Case Report", Infection and Chemotherapy, 54(1), pp.208~212 (2022), 대한감염학회[DOI]